Protein Assays Market | Market Insights & Competitive Analysis

 

The Bradford Protein Assay can be used extensively for analysis of proteins in several applications including drug discovery, food safety, and medical diagnostics. The assays will also be useful in the analysis of numerous proteins complexes that have been detected by various methods. The idea of this assay is based on the interaction of protein molecules with fluorescent dye under acidic conditions causing a bluish color shift from blue to red. This technique actually determines the presence of all basic amino acids, arginine, glycine and histidine that results in formation of the co-enzymatic protein complex. It may be used in combination with other methods for evaluation of protein content.

Market Insights

Significant growth in the pharmaceutical sector is likely to propel growth of the global Protein Assays Market. For instance, according to The European Federation of Pharmaceutical Industries and Associations'Key Data 2019, the pharmaceutical sector in Europe invested US$ 19, 509 million in 2000, which risen up to US$ 39,895 million (est.) in 2018. Moreover, launch of graphene-based electrochemical biosensors can also be likely to assist in growth of the market. For instance, in February 2018, Nanomedical Diagnostics launched Graphene Biosensor- FLEX, which can be easily integrated with company's Agile R100 protein assay system to increase the efficiency of the drug discovery process.

Among regions, Europe is likely to witness significant growth in the protein assays market, owing to growing pharmaceutical sector. For instance, according to The European Federation of Pharmaceutical Industries and Associations'Key Data 2019, the pharmaceutical sector in Europe was valued at US$ 139, 287 million in 2000, which risen up to US$ 284, 028 million (est.) in 2018.

Emergence of Covid-19 is expected to improve adoption of protein assays to detect antibodies against various proteins of coronavirus. For instance, in August 2020, Eurofins launched multiple serological assay methods to detect antibodies targeted from the Nucleocapsid protein of the novel coronavirus.

Competitive Analysis

Major players operating in the global Protein Assay Market include, Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza Group, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Eurofins, AYOXXA Biosystems GmbH, Cell Signaling Technology, Inc., and Geno Technology Inc.

January 2019: AYOXXA Biosystems GmbH signed a study agreement with one of the leading pharmaceutical companies (details weren't disclosed) for the development of a series of low volume, high sensitivity multiplex protein assays want to validate protein biomarkers in the field of ophthalmology.